Biocenter Finland evaluation under way

Biocenter Finland Scientific Advisory Board (SAB) is currently evaluating BF technology platforms. During Monday August 22 and Tuesday August 23 the SAB evaluates the current technology platforms and new proposals for technology platforms and emerging technologies.

The SAB is chaired by Professor Carl-Henrik Heldin (Ludwig Institute for Cancer Research, Uppsala) and members are Ole-Petter Ottersen (University of Oslo), Marja Jäättelä (Institute of Cancer Biology, Copenhagen), Richard J. Roberts (New England Biolabs, Ipswich, MA) and Matthias Wilmanns (EMBL, Hamburg).

 

Featured articles